Article
Pharmacology & Pharmacy
Malick Bio Idrissou, Alexandre Pichard, Bryan Tee, Tibor Kibedi, Sophie Poty, Jean-Pierre Pouget
Summary: Auger electron emitters (AEEs) are used in targeted radionuclide therapy to irradiate tumor cells specifically while protecting healthy tissues. Radioimmunoconjugates (RIC) have been developed for tumor cell targeting and transportation to the nucleus, with NLS and TAT peptides improving nuclear uptake of In-111-trastuzumab conjugates, albeit with limited and non-specific effects. In-111 also contributes to non-specific cytotoxicity in vitro, and further research is needed to develop more effective Auger-based radiopharmaceuticals.
Article
Medicine, Research & Experimental
Bas M. Bavelaar, Lei Song, Mark R. Jackson, Sarah Able, Ole Tietz, Irini Skaripa-Koukelli, Philip A. Waghorn, Martin R. Gill, Robert C. Carlisle, Madalena Tarsounas, Katherine A. Vallis
Summary: In this study, gold nanoparticles (AuNPs) were used to enhance cellular uptake of oligonucleotides targeting telomerase. The addition of Tat to AuNPs increased nuclear localization and induced DNA double-strand breaks in telomerase-positive cells. In-111-Match-AuNP-Tat shows promise as a vector for delivering radionuclides to cancer cells while sensitizing them to the effects of emitted radiation.
MOLECULAR PHARMACEUTICS
(2021)
Review
Biology
Roger W. Howell
Summary: This article reviews the research in the field of Auger processes from 2015 to 2019 and points out future research directions. It is an important study with significant implications for the fields of physics, chemistry, biology, and medical science.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Joe O. Donoghue, Pat Zanzonico, John Humm, Adam Kesner
Summary: This article discusses the dose prescription algorithms, patient-specific dosimetry workflow, and advantages and disadvantages of alpha-particle emitters for radiopharmaceutical therapy.
JOURNAL OF NUCLEAR MEDICINE
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Francesca Borgna, Stephanie Haller, Josep M. Monne Rodriguez, Mihaela Ginj, Pascal Grundler, Jan Rijn Zeevaart, Ulli Koster, Roger Schibli, Nicholas P. van der Meulen, Cristina Mueller
Summary: The study found that [Tb-161]Tb-DOTA-LM3 was more effective in inhibiting tumor cell viability compared to [Lu-177]Lu-DOTA-LM3 in both in vitro and in vivo experiments. In mice studies, [Tb-161]Tb-DOTA-LM3 significantly delayed tumor growth and prolonged survival compared to [Lu-177]Lu-DOTA-LM3. Terbium-161 also showed therapeutic advantages over lutetium-177 when combined with DOTATOC.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Biology
Jihad Karam, Julie Constanzo, Alexandre Pichard, Laurent Gros, Joel Chopineau, Marie Morille, Jean-Pierre Pouget
Summary: This study investigated the effects of sEVs produced by irradiated cells on bystander cytotoxic effects and therapeutic efficacy. In vitro experiments showed that sEVs had cytotoxic effects on recipient cells. However, no systemic effects were observed in vivo.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Sreeja Sreekumar, Dong Zhou, Cedric Mpoy, Elsa Schenk, Jalen Scott, Jeffrey M. Arbeit, Jinbin Xu, Buck E. Rogers
Summary: This study identified PARP-1 as an attractive target for therapeutic strategies in advanced prostate cancer. Synthesized radio-brominated Auger emitting inhibitor, [Br-77]Br-WC-DZ, induced DNA damage, cell cycle arrest, and cytotoxicity in prostate cancer cells. The findings provide a strong rationale for future clinical investigation.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Alex Rigby, Julia E. Blower, Philip J. Blower, Samantha Y. A. Terry, Vincenzo Abbate
Summary: Thallium-201 is attractive for molecular radionuclide therapy due to its Auger electron emissions, but chemical platforms for developing targeted radiopharmaceuticals are currently unavailable. Oxidation of [Tl-201]Tl(I) to chelatable [Tl-201]Tl(III) and challenges in stable chelation of thallium were investigated to support future synthesis of effective [Tl-201]-labelled radiopharmaceuticals.
NUCLEAR MEDICINE AND BIOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Caroline Stokke, Monika Kvassheim, Johan Blakkisrud
Summary: This review focuses on the physical characteristics of radionuclides that are relevant for radionuclide therapy, and points out that these characteristics vary considerably between different radionuclides. The selection of different characteristics should be optimized based on specific therapeutic targets, and some characteristics may be advantages for certain applications but drawbacks for others.
Article
Radiology, Nuclear Medicine & Medical Imaging
Karina Lindbog Madsen, Anne Sofie Nautrup Therkelsen, Niels Langkjaer, Birgitte Brinkmann Olsen, Helge Thisgaard
Summary: In this study, it was found that the treatment of GBM cells with F-UdR in combination with [I-125]I-UdR led to a significant increase in DNA incorporation and a decrease in cell viability. Furthermore, the therapeutic effects were further increased when TMZ was combined with [I-125]I-UdR, showing promising potential for future therapeutic treatment options for glioblastoma patients.
NUCLEAR MEDICINE AND BIOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Julie Bolcaen, Mohamed A. Gizawy, Samantha Y. A. Terry, Antonio Paulo, Bart Cornelissen, Aruna Korde, Jonathan Engle, Valery Radchenko, Roger W. Howell
Summary: Auger electron (AE) radiopharmaceutical therapy (RPT) may have therapeutic efficacy similar to α-particles for small oncologic diseases, with lower risks of normal tissue toxicity. Despite accumulating knowledge about AE research, the promise of AE RPT has not yet been realized, with only a few agents evaluated in clinical trials.
JOURNAL OF NUCLEAR MEDICINE
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Katarzyna M. Osytek, Philip J. Blower, Ines M. Costa, Gareth E. Smith, Vincenzo Abbate, Samantha Y. A. Terry
Summary: Thallium-201 (Tl-201) has potential therapeutic effects on cancer cells when internalized, reducing clonogenic survival and increasing nuclear DNA damage. Further development and evaluation of Tl-201 therapeutic radiopharmaceuticals are justified based on these findings.
Article
Chemistry, Inorganic & Nuclear
Hamed Bastami, Tayebeh A. Chiniforoush, Samira Heidari, Mahdi Sadeghi
Summary: The study evaluates the dose induced by Auger electrons emitted from Sb-119 in a tumor and surrounding healthy tissues, highlighting the significance of accurate target therapy planning based on the absorbed dose calculations.
APPLIED RADIATION AND ISOTOPES
(2022)
Review
Pharmacology & Pharmacy
Kushal Chakraborty, Jagannath Mondal, Jeong Man An, Jooho Park, Yong-Kyu Lee
Summary: Radiopharmaceutical therapy, introduced over 80 years ago, has revolutionized cancer treatment by enabling simultaneous detection and treatment of tumors. Through the development of radioactive radionuclides and functional radiolabeled peptides, biomolecules and therapeutics have been produced and extensively utilized in radio medicine. Advanced technologies such as functional peptide conjugation and incorporation of radionuclides into chelating ligands have enabled precise and targeted cancer therapy while minimizing damage to surrounding normal tissue. Furthermore, the development of theragnostic radionuclides has allowed for more accurate targeting and monitoring of treatment response.
Review
Chemistry, Physical
Francisco Silva, Maria Paula Cabral Campello, Antonio Paulo
Summary: Nanotechnology has provided novel methodologies and tools in medical oncology, particularly the use of gold nanoparticles in radiopharmaceutical development, offering nanometric platforms for nuclear imaging and/or radionuclide therapy. Numerous studies have shown the potential and significance of gold nanoparticles in cancer treatment.
Review
Biology
Andrey A. Rosenkranz, Tatiana A. Slastnikova, Mikhail O. Durymanov, Georgii P. Georgiev, Alexander S. Sobolev
Summary: This review discusses the development of effective anticancer agents for delivering AE emitters into the nuclei of target cancer cells. The use of peptide-based conjugates, nanoparticles, recombinant proteins, and other constructs for targeted intranuclear delivery of AE emitters, as well as their advantages and limitations, are discussed.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
(2023)
Review
Medicine, Research & Experimental
Alexey Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev, Alexander S. Sobolev
Summary: The Nrf2 transcription factor regulates the expression of genes involved in cell defense against oxidative stress, which is associated with various diseases. The interactions between Nrf2 and Keap1 protein play a crucial role in this regulation. The activation of the Nrf2 system is considered as a promising strategy to treat diseases related to oxidative stress, including COVID-19. Two approaches are being developed to inactivate the Keap1 guardian function and enhance Nrf2 activity.
Article
Pharmacology & Pharmacy
Yuri V. Khramtsov, Alexey V. Ulasov, Andrey A. Rosenkranz, Tatiana A. Slastnikova, Tatiana N. Lupanova, Georgii P. Georgiev, Alexander S. Sobolev
Summary: To compare the effectiveness of bioactive agents in cells, it is important to assess their effective concentrations. This work proposes a method to evaluate the effective concentrations of bioactive agents and target proteins based on a simple equilibrium model and the CETSA. The method was tested by analyzing the concentrations of Nrf2 and Keap1 proteins in different cell lines and comparing them with literature data. This approach allows for the analysis of protein-protein or molecule-protein interactions in the cell and can be useful in studying drug delivery systems.
Article
Pharmacology & Pharmacy
Tatiana A. Slastnikova, Andrey A. Rosenkranz, Alexey V. Ulasov, Yuri V. Khramtsov, Tatiana N. Lupanova, Georgii P. Georgiev, Alexander S. Sobolev
Summary: In this study, we developed a mouse syngeneic melanoma model with preserved in vivo expression of human EGFR and tested its functionality. This model has important applications for high-throughput in vivo screening of EGFR-targeting agents.
Article
Biochemistry & Molecular Biology
T. N. Lupanova, A. V. Ulasov, Y. V. Khramtsov, A. A. Rozenkranz, G. P. Georgiev, A. S. Sobolev
Summary: A modular nanotransporter (MNT) carrying an antibody-like molecule, anti-c-Myc nanobody, was synthesized and characterized. It was found that the MNT could bind to the target protein, c-Myc oncogene, with a dissociation constant of 46 +/- 14 nM. Moreover, the MNT was able to internalize into target cells, alter Myc-dependent expression, and exhibit antiproliferative effects.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS
(2023)
Review
Pharmacology & Pharmacy
Andrey A. Rosenkranz, Tatiana A. Slastnikova
Summary: A large variety of proteins have been used successfully for the treatment of different diseases, especially cancer. While most drugs target cell surface proteins, the majority of therapeutic targets are actually located inside the cell. Traditional low molecular weight drugs can penetrate all cells, causing side effects. Recent studies focus on designing multifunctional proteins to overcome these challenges and deliver drugs to the desired intracellular compartment of target cells. This review discusses the application of artificial constructs for targeted delivery of protein-based and low molecular weight drugs, as well as the obstacles and means to overcome them.
Article
Optics
Behrokh Beiranvand, Rustam A. Khabibullin, Alexander S. Sobolev
Summary: In this paper, the authors investigate the enhancement of local electric fields in a nanoplasmonic crystal due to the existence of photonic edge states. They demonstrate that these states can be excited by incident waves and are localized along line defects in the crystal. Numerical simulations show a 12-fold enhancement of the electric field for incident plane waves at a wavelength of 545 nm. This effect can be utilized to improve the sensitivity of SERS spectroscopy, increase the Purcell factor of quantum systems, and enhance higher harmonic generation.
Review
Pharmacology & Pharmacy
Honoka Obata, Mikako Ogawa, Michael R. Zalutsky
Summary: The present review explores potential targets/partners for future targeted radionuclide therapy (TRT) strategies. It discusses key factors in the cancer genome, such as DNA damage response/repair and maintenance systems, that contribute to the survival of cancer cells despite receiving high radiation doses. The review suggests targeting DNA maintenance factors as a promising strategy to enhance the effectiveness of TRT, considering their cancer-specific abilities and dysregulated systems.
Article
Radiology, Nuclear Medicine & Medical Imaging
Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan, Michael R. Zalutsky
Summary: This study evaluates the therapeutic potential of single-domain antibody fragments (sdAbs) combined with alpha-particle therapy for HER2-expressing cancers. The results demonstrate that HER2-specific sdAbs, such as 5F7 and VHH_1028, show better efficacy in tumor growth inhibition compared to HER2-irrelevant VHH_2001, suggesting that combining high-affinity HER2-targeted sdAbs with a residualizing prosthetic agent is a promising strategy for targeted alpha-particle therapy.
JOURNAL OF NUCLEAR MEDICINE
(2023)
Article
Oncology
Daniele Procissi, Stephen A. Jannetti, Markella Zannikou, Zhengyuan Zhou, Darryl McDougald, Deepak Kanojia, Hui Zhang, Kirsten Burdett, Ganesan Vaidyanathan, Michael R. Zalutsky, Irina Balyasnikova
Summary: Low-level brain irradiation induces dynamic changes in tumor vasculature, which increase the delivery of anti-HER2 VHH to intracranial tumors. This finding could facilitate the detection, monitoring, and treatment of HER2-expressing brain metastases.
NEURO-ONCOLOGY ADVANCES
(2022)